More Articles on

Tagged Articles

March 21, 2024

Call for Resolutions to AAFP COD

Deadline: July 1, 2024

March 11, 2024

Opioid Use Disorder: Medicare Pays for Certain Treatment Services

Medicare pays for opioid use disorder (OUD) screenings performed by physicians and non-physician practitioners.

March 07, 2024

Opioid Use Disorder: Medicare Pays for Certain Treatment Services

Medicare pays for opioid use disorder (OUD) screenings performed by physicians and non-physician practitioners.

January 02, 2024

In Memory of Christne Marino, MD, FAAFP

It is with a heavy heart that we share the passing of MDAFP past president, Christine Marino, MD, FAAFP. Please view her obituary for more information about her life and the funeral on January 4.

December 13, 2023

Maryland Medicaid’s Preferred Drug List (PDL)

Effective January 1, 2024

October 09, 2023

COVID-19: Updated Novavax COVID-19 Vaccine, Adjuvanted for Patients 12 & Older

On October 3, the FDA amended the emergency use authorization of the Novavax COVID-19 vaccine, Adjuvanted to include the 2023–2024 formula.

September 27, 2023

50 Things You Should Know about FASD During FASD50

September is Fetal Alcohol Spectrum Disorder (FASD) awareness month, and AAFP has just launched a few resources for members.

August 15, 2023

Immunization: Protect Your Patients

Fewer than 25% of adults get their recommended vaccines, and minority populations have even lower immunization rates

June 26, 2023

MATE Act Training Resources

The training requirement is for prescribers of controlled substances in schedules II, III, IV, and V to complete a one-time, eight-hour training prior to their first registration or renewal of their DEA license.

June 14, 2023

Maryland Medicaid’s Preferred Drug List (PDL) – July 1, 2023

The Office of Pharmacy Services (OPS) wants to alert you to updates to the Maryland Medicaid’s Preferred Drug List (PDL) and Brand Preferred over Generic Program, effective July 1, 2023.